Ariad Pharma (ARIA) Posts Narrower than Expected Q1 Loss
Tweet Send to a Friend
Ariad Pharma (NASDAQ: ARIA) reported Q1 EPS of ($0.36), $0.02 ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
